Research Leader Says Discovery Offers Hope Early Alzheimer’s Disease Can Be Cured
Team uncovers new explanation for the spread of key protein, Tau, within the brain
March 1, 2010 – A researcher who has spent over 20 years studying Alzheimer’s on the cellular level thinks his team has made a discovery that he thinks offers hope that patients in early stages of the disease might someday be cured. The work by his team is published in the February issue of the Journal of Alzheimer’s Disease.
The researchers from the UMass Lowell Center for Cellular Neuroscience and Neurodegeneration Research have found a new mechanism by which a key protein associated with Alzheimer’s disease can spread within the human brain.
The team, led by UMass Lowell biological sciences professor Garth Hall, provides a new explanation of how the protein tau, a normal human protein that becomes toxic in Alzheimer’s patients, can appear in their cerebrospinal fluid (CSF).
“My team has discovered two different ways in which tau is secreted by neurons, or brain cells,” said Hall, who has spent more than 20 years studying Alzheimer’s on the cellular level using larval sea lampreys as a model system.
“This might explain how tau-containing lesions seem to propagate between adjacent, interconnected parts of the brain during the development of the disease.”
Until very recently, it was universally assumed by scientists that tau is never secreted from or transferred between neurons, and that CSF-tau only appears after many neurons have died and irreversible harm has been done to the brain.
“That tau secretion can occur via two distinct mechanisms strongly indicates that it is biologically ‘real’ and is not just tau protein leaking out of dead neurons,” said Hall.
“The fact that it occurs in a pattern that reproduces what is seen in the CSF of Alzheimer’s patients holds out hope that patients in early stages of the disease might someday be cured. If we can distinguish secreted tau from tau that is released from dying neurons in CSF samples, then maybe we can diagnose Alzheimer’s in time to stop the disease before the neurons die.”
Hall, together with graduate student WonHee Kim and UMass Lowell, has filed a provisional patent application in connection with a novel approach to the early diagnosis of Alzheimer’s that is based on their studies of tau secretion.
As many as 5.3 million people in the United States are living with the disease, according to the Alzheimer’s Association. The seventh-leading cause of death among senior citizens, Alzheimer’s is the most common form of dementia and will soon become America’s most expensive health care burden.
Original content HERE.
Visit www.andelcare.com for information and assistance with home care for an aging loved one in the Seattle and Bellevue WA areas.